InvestorsHub Logo

mog1962

03/11/17 12:14 PM

#13839 RE: Munchqin #13838

Sadly it may well be a great tax write-off for you or anyone else who got in high during the Nano hey-day or before. That might prove good for you if, as the overall market rises, you have some substantial gains to shelter in the next year or two.

Alternatively, if you buy down here and are confident it will not completely tank under the guidance of CM, then you can hope for some dead-cat bounce or a bit of a flurry up to about 20 cents or so and take some profits as well. I doubt we will see the 50 cents that Mir bragged about for his first few months that may have had nothing to do with his arrival even though he took full credit (much like yesterdays labor report and some recent metrics more attributable to what occurred prior to the DT inauguration than any actions since).

powderbum

03/11/17 2:12 PM

#13842 RE: Munchqin #13838

"Zero Scientific merits" That's liable.

Journal of Hospice and Palliative Medicine showing an amazing 95% reduction in pain on the average for patients with PHN. http://www.ncbi.nlm.nih.gov/pubmed/23838448?dopt=Abstract

When Have you ever seen a study with a 95% reduction in pain with NO side effects? Never in the history of mankind!

http://www.calmarett.com/media/pdf/JPSM%20Pilot%20Trial%20Sept2010.pdf

The Massey Cancer Center recently announced the completion of a back study with a sham device. The study showed a significant difference in pain reduction between the Calmare patients and those treated with the sham device.http://www.clinicaltrials.gov/ct2/show/results/NCT01896687?term=calmare&rank=3 (This study shows Calmare works for back pain and is not a placebo)

http://www.jpsmjournal.com/article/S0885-3924(11)00264-8/abstract. 91% vs. 28% for the drugs. It's like beating up your little sister.

http://meetinglibrary.asco.org/content/130046-144.




In addition there are studies from Italy,The Middle East, Korea and India confirming the efficacy of Calmare.

The FDA only requires 20% efficacy. Calmare is over 50% in a bad study. WITH NO SIDE EFFECTS, they blow the drug companies away.